Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies.
Egger AE, Sahanic S, Gleiss A, Ratzinger F, Holzer B, Irsara C, Binder N, Winkler C, Binder CJ, Posch W, Loacker L, Hartmann B, Anliker M, Weiss G, Sonnweber T, Tancevski I, Griesmacher A, Löffler-Ragg J, Hoermann G. Egger AE, et al. Among authors: posch w. Microbiol Spectr. 2022 Dec 21;10(6):e0059722. doi: 10.1128/spectrum.00597-22. Epub 2022 Oct 12. Microbiol Spectr. 2022. PMID: 36222681 Free PMC article.
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E, Diem G, Witting C, Zaderer V, Bellmann-Weiler RM, Reindl M, Bauer A, Griesmacher A, Fux V, Hoermann G, Miller C, Zabernigg A, Wöll E, Wilflingseder D, Lass-Flörl C, Posch W. Lafon E, et al. Among authors: posch w. Front Immunol. 2021 Jun 14;12:684014. doi: 10.3389/fimmu.2021.684014. eCollection 2021. Front Immunol. 2021. PMID: 34194438 Free PMC article.
Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern.
Diem G, Dichtl S, Zaderer V, Lass-Flörl C, Reindl M, Lupoli G, Dächert C, Muenchhoff M, Graf A, Blum H, Keppler OT, Wilflingseder D, Posch W. Diem G, et al. Among authors: posch w. Microbiol Spectr. 2023 Aug 8;11(5):e0179323. doi: 10.1128/spectrum.01793-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37551989 Free PMC article.
SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19.
Sahanic S, Hilbe R, Dünser C, Tymoszuk P, Löffler-Ragg J, Rieder D, Trajanoski Z, Krogsdam A, Demetz E, Yurchenko M, Fischer C, Schirmer M, Theurl M, Lener D, Hirsch J, Holfeld J, Gollmann-Tepeköylü C, Zinner CP, Tzankov A, Zhang SY, Casanova JL, Posch W, Wilflingseder D, Weiss G, Tancevski I. Sahanic S, et al. Among authors: posch w. Heliyon. 2023 Nov 17;9(11):e21893. doi: 10.1016/j.heliyon.2023.e21893. eCollection 2023 Nov. Heliyon. 2023. PMID: 38034686 Free PMC article.
Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.
Theurl M, Nairz M, Schroll A, Sonnweber T, Asshoff M, Haschka D, Seifert M, Willenbacher W, Wilflingseder D, Posch W, Murphy AT, Witcher DR, Theurl I, Weiss G. Theurl M, et al. Among authors: posch w. Haematologica. 2014 Sep;99(9):1516-24. doi: 10.3324/haematol.2013.099481. Epub 2014 Jun 3. Haematologica. 2014. PMID: 24895335 Free PMC article.
96 results